Skip to content
  • Saturday, 15 August 2026
  • 3:07 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • NTU Singapore Scientists Revolutionize Optical Skyrmion Production Using 200-Year-Old Classic Physics Experiment
Advanced Materials Science

NTU Singapore Scientists Revolutionize Optical Skyrmion Production Using 200-Year-Old Classic Physics Experiment

Nila Kartika Wati Jul 14, 2026 0

Researchers at Nanyang Technological University, Singapore (NTU Singapore) have achieved a significant breakthrough in the field of photonics by developing…

Read More
Neuroscience & Brain Research

Artificial Intelligence Struggles with Cognitive Control as Leading Models Falter in Classic Stroop Test Experiments

Rifan Muazin Jun 15, 2026 0

The rapid evolution of artificial intelligence has led to the development of systems capable of passing bar exams, diagnosing rare…

Read More
Agentic AI-powered literature reviews: Reduce research burdens and accelerate insightsLudwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous LeukemiaGinkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&DThe Creatures’ Guide to Caring: Unveiling the Universal Art of Parenting Through the Animal Kingdom
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ